According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacter
According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacterium pseudolongum of the present invention are also provided.
대표청구항▼
1. A food composition comprising: a biologically pure culture of strain Bifidobacterium pseudolongum AHC7, NCIMB 41199, or mutant strain thereof, wherein the strain has probiotic activity in a companion animal selected from a canine, a feline, a rabbit, a ferret, a horse, and a cow; anda component c
1. A food composition comprising: a biologically pure culture of strain Bifidobacterium pseudolongum AHC7, NCIMB 41199, or mutant strain thereof, wherein the strain has probiotic activity in a companion animal selected from a canine, a feline, a rabbit, a ferret, a horse, and a cow; anda component comprising protein, fat, and carbohydrate,wherein the food composition is in a form selected from a biscuit, a kibble, a yogurt, a gravy, and any combination thereof, and furtherwherein the Bifidobacterium pseudolongum strain survives and colonizes the gastrointestinal tract of the companion animal. 2. The food composition according to claim 1, wherein the strain adheres to gut epithelial cells of the companion animal at a level of at least 4%. 3. The food composition according to claim 1, wherein the strain has a growth of at least 33% in the presence of 0.5% bile salts. 4. The composition according to claim 1, wherein the strain is able to maintain viability following 1 hour at pH 2.5. 5. The food composition of claim 1, wherein the mutant strain is a natural, genetically modified, or induced mutant strain. 6. The food composition of claim 1, wherein the companion animal is a dog. 7. The food composition of claim 1, wherein the companion animal is a cat. 8. A composition comprising a biologically pure culture of strain Bifidobacterium pseudolongum AHC7, NCIMB 41199, or a mutant strain thereof, anda food composition comprising protein, fat, and carbohydrate, wherein the food composition is in a form selected froma biscuit, a kibble, a yogurt, a gravy, a dairy product, and any combination thereof;wherein the strain is present in an amount effective to have probiotic activity in a companion animal selected from a canine, a feline, a rabbit, a ferret, a horse, and a cow, andwherein the strain survives and colonizes the gastrointestinal tract of the companion animal. 9. The composition according to claim 8, wherein the strain adheres to gut epithelial cells of the companion animal at a level of at least 4%. 10. The composition according to claim 8, wherein the strain has a growth of at least 33% in the presence of 0.5% bile salts. 11. The composition according to claim 8, wherein the strain is able to maintain viability following 1 hour at pH 2.5. 12. The composition according to claim 8, wherein the mutant strain is a natural, genetically modified, or induced mutant strain. 13. The composition according to claim 8, wherein the companion animal is a dog. 14. The composition according to claim 8, wherein the companion animal is a cat. 15. The composition according to claim 8, wherein the composition is a companion animal food. 16. The composition according to claim 15, wherein the composition is a dog food. 17. The composition according to claim 15, wherein the composition is a cat food. 18. The composition according to claim 8, wherein the composition is a gravy. 19. The composition according to claim 8, further comprising at least one of a metabolite, a homogenate, a protein, an extract, and a ferment supernatant of the strain Bifidobacterium pseudolongum AHC7, NCIMB 41199, or a mutant strain thereof. 20. A composition comprising: the isolated strain of Bifidobacterium pseudolongum AHC7, NCIMB 41199; and a component comprising protein, fat, and carbohydrate,wherein the composition is in a form selected from a biscuit, a kibble, a yogurt, a gravy, and any combination thereof,wherein the isolated strain has probiotic activity in a companion animal selected from a canine, a feline, a rabbit, a ferret, a horse, and a cow, and wherein the strain survives and colonizes the gastrointestinal tract of the companion animal.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (189)
Rizzi George P. (Cincinnati OH), (S)-3-Amino-4-[(S,S)-1-(1-hydroxyethyl)alkyl amino]-4-oxo-butyric acid compounds suitable as non-nutritive sweetners.
Leonard Walter G. (1017 Main St. Melrose MA 02176) Doble ; Jr. Henry P. (Sunnyview Dr. Redding CT 06875) Nuckols Walter S. (119 Putnam Park Rd. Bethel CT 06801), Calendar-oriented pill dispenser.
Henderson, Todd R.; Lippiello, Louis; Filburn, Charles; Griffin, David, Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals.
Rochat, Florence; Schiffrin, Eduardo; Guigoz, Yves, Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters.
Marttila Esko (Perttula FIX) Larma Ilkka (Espoo FIX) Vahervuo Kari (Espoo FIX) Uotila Jaakko (Espoo FIX), Composition for the oral administration of pharmaceuticals.
Sinclair, David A.; Howitz, Konrad T.; Zipkin, Robert E.; Bitterman, Kevin J.; Lamming, Dudley W., Compositions for manipulating the lifespan and stress response of cells and organisms.
Lamothe Jean-Pierre H. G. (Toulouse FRX) Marchenay Yves G. (Boulogne FRX) Monsan Pierre F. (Blagnac FRX) Paul Francois M. B. (Toulouse FRX) Pelenc Vincent (Toulouse FRX), Cosmetic compositions containing oligosaccharides.
Reddy Malireddy S. (6983 S. Telluride St. Aurora CO 80016), Enhancement of lactobacillus acidophilus growth and viability in yogurt and other cultured dairy products.
Collings George F. (Auburn KS) Stout Neil P. (Topeka KS) Cowell Christopher S. (Topeka KS) Plas Stephen J. (Topeka KS), Extruded dog treat food product having improved resistance to breakage.
Reid Gregor (London CAX) Bruce Andrew W. (Toronto CAX), Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections.
Vidal, Karine; Donnet-Hughes, Anne; Granato, Dominique-Anne; Corthesy-Theulaz, Irene, Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria.
Piccirilli, Antoine; Piccardi, Nathalie; Msika, Philippe; Paul, François; Bredif, Stéphanie, Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency.
Piccirilli, Antoine; Piccardi, Nathalie; Msika, Philippe; Paul, François; Bredif, Stéphanie, Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency.
Piccirilli, Antoine; Piccardi, Nathalie; Msika, Philippe; Paul, François; Bredif, Stéphanie, Medicament comprising a peptide extract of avocado, which is intended for the treatment and prevention of illnesses that are linked to an immune system deficiency or oxidative stress or skin ageing or dry skin.
Nahill Edmond P. (56 Pleasant St. Methuen MA 01844) Nahill James C. (9 Sunset Ave. Methuen MA 01844) Nahill William A. (10 Glen Ave. Methuen MA 01844) Nahill Arthur (51 East St. Methuen MA 01844), Medicine dispensing system.
Pitha, Josef; Roth, George S; Hayek, Michael Griffin; Massimino, Stefan Patrick; Ceddia, Michael Anthony; Davenport, Gary Mitchell; Burr, John Russell, Method of maintaining and/or attenuating a decline in quality of life.
Chen, Hao; Liu, Ming; Sathyamoorthy, Malathi; Su, Qi; Leary, Lisa; Zhong, Wayne Shaobin, Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions.
Lin, Hungwei Charlie; Clark, III, Harry Mead; Pope, Brent Karl; Millican, Jerry Don; Ghorpade, Viswas; Fritsch, Dale Allen, Methods for extending the shelf-life of food compositions containing polyunsaturated fatty acids.
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Methods of use of probiotic Lactobacilli for companion animals.
Boileau, Thomas William-Maxwell; Ceddia, Michael Anthony; Davenport, Gary Mitchell; Kiely, Barry Pius; O'Mahony, Liam Diarmuid; Sunvold, Gregory Dean; Tetrick, Mark Alan; Vickers, Robert Jason, Methods of use of probiotic for companion animals.
Sozzi Tomaso (Lausanne CHX) Schrenk Alfred (Orbe CHX) Buhler Marcel (Tolochenaz CHX), Microcapsule containing a microorganism and a process for its production.
Stern Norman J. (Athens GA) Bailey J. Stan (Athens GA) Cox ; Jr. Nelson A. (Athens GA) Blankenship Leroy C. (Athens GA), Nucosal competitive exclusion flora.
Garcia-Rodenas, Clara Lucia; Bergonzelli, Gabriela; Rochat, Florence; Turini, Marco Enrico; Corthesy-Theulaz, Irène; Cherbut, Christine, Nutritional formula for optimal gut barrier function.
Dittmar, Gregory Paul; Amante, Joseph Michael; Cronk, Tony Ryan; Newby, Daniel Gary, Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures.
Grahn Eva E. (Bondegatan 32 UmeS-902 54 SEX) Holm Stig E. F. (Gimonsvgen 25 UmeS-902 40 SEX), Pharmaceutical preparation for controlling pathogenic intestinal bacteria.
Hatano Harumi,JPX ; Ito Takahiro,JPX ; Ishibashi Takashi,JPX ; Yoshino Hiroyuki,JPX ; Mizobe Masakazu,JPX, Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract.
Ikushima Heiji (Saitama-ken JPX), Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the int.
Plail, Regina; Schatzmayr, Gerd; Binder, Eva Maria; Mohnl, Michaela; Klimitsch, Alfred; Nitsch, Sabine; Klose, Viviana, Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof.
Rutherford William M. (Des Moines IA) Allen Jack E. (Boonville IA) Schlameus Herman W. (San Antonio TX) Mangold Donald J. (San Antonio TX) Harlowe ; Jr. William W. (San Antonio TX) Lebeda Joseph R. (, Process for preparing rotary disc fatty acid microspheres of microorganisms.
Reimann Josef (Kirchlintein-Hohenaverbergen DEX) Sirel Tas (Verden-Walle DEX) Steinberg Eckhart (Verden DEX) Hornig Rolf (Kirchlintein-Luttum DEX) Czempik Klaus (Minden DEX) Khler Friedrich (Martfeld, Process for the production of a lumpy meat emulsion product.
Miller James G. (Ellicott City MD) Wax Michael J. (Bethesda MD) Wormsbecher Richard F. (Highland MD) Aller Leo B. (Severna Park MD) Durham Donald R. (Gaithersburg MD) Chmurny Alan B. (Frederick MD), Process upset-resistant inorganic supports for bioremediation.
Shenouda Soliman (Tarrytown NY) Clausi Adolph (Cos Cob CT) Rogers Ann M. (Rivervale NJ) El-Hag Nabil (Putnam Valley NY), Reduction of microbial population on surface of food materials.
Reddy Malireddy S. (6983 S. Telluride St. Aurora CO 80016), Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconos.
DeNeale Richard J. (Morrisonville NY) Guley Paul C. (Plattsburgh NY) Milosovich George (Rouses Point NY), Sustained release pharmaceutical compositions.
Friedman Mark I. (Merion PA) Tordoff Michael G. (Philadelphia PA) DiNovi Michael J. (Philadelphia PA) Rafka Robert J. (Ardmore PA), Use of 2,5-anhydro-D-mannitol as a food intake modifier.
De Simone, Claudio, Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.